EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

New Anti‐Fibrotic Strategies for Keloids: Insights From Single‐Cell Multi‐Omics

Songyun Zhao iD, Jiaheng Xie iD, Qian Zhang, Tianyi Ni, Jinde Lin, Weicheng Gao, Liping Zhao, Min Yi, Liying Tu, Pengpeng Zhang iD, Dan Wu, Qikai Tang and 5 more

Cell Proliferation · 2025-06 · 58 (6)

DOI: 10.1111/cpr.13818 ↗

At a glance

Journal article in Cell Proliferation, published online on 2025-02-04. Written by Songyun Zhao and 16 co-authors. Institution: Department of Plastic Surgery, The Affiliated Friendship Plastic Surgery Hospital of Nanjing Medical University, Nanjing, China. Major MEDLINE topics: Keloid, Single-Cell Analysis. Cited 33 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Keloids are complex pathological skin scars characterised by excessive growth of fibrous tissue and abnormal accumulation of extracellular matrix (ECM). Despite various treatment options available, the treatment of keloids remains a major clinical challenge due to high recurrence rates and inconsistent therapeutic outcomes. By collecting three keloid tissues and three normal skin samples and utilising single‐cell RNA sequencing (scRNA‐seq), we delved into the cellular heterogeneity and molecular mechanisms of keloids. Our study identified multiple fibroblast subpopulations within keloid tissue. Enrichment and cell–cell communication analyses revealed that POSTN‐positive mesenchymal fibroblasts (POSTN+ mesenchymal fibs) are more prevalent in keloids and exhibit higher transforming growth factor β (TGF‐β) signalling activity, potentially playing a central role in excessive fibrosis. In contrast, IGFBP2‐positive fibroblasts (IGFBP2+ fibs) are more abundant in normal skin, insensitive to TGF‐β and Periostin signalling, and possess anti‐fibrotic potential, possibly related to limited tissue repair and regenerative capacity. Trajectory analysis inferred the differentiation states and patterns of different fibroblast subpopulations. Additionally, we explored the heterogeneity of endothelial cells, finding an endothelial cell subpopulation (EC10) exhibiting mesenchymal activation characteristics, which may work with specific fibroblasts to promote abnormal angiogenesis and endothelial‐to‐mesenchymal transition processes. Spatial transcriptomics analysis has shown that the proportion of IGFBP2+ fibroblasts relatively increases in acne keloidalis after hormonal treatment, further demonstrating their value as potential therapeutic targets. Ultimately, we separated these two subpopulations using flow cytometry, highlighting their opposing roles in the secretion of the ECM. These findings provide new insights into the pathogenesis of keloids and lay the theoretical foundation for the development of innovative anti‐fibrotic treatment strategies.

Subjects

MeSH terms (MEDLINE)

KeloidSingle-Cell AnalysisHumansFibroblastsFibrosisTransforming Growth Factor betaSkinExtracellular MatrixSignal TransductionCell Adhesion MoleculesInsulin-Like Growth Factor Binding Protein 2FemaleMaleEndothelial CellsAdultMultiomics

Author keywords

TGF‐βanti‐fibrotic therapyfibroblastskeloidscRNA‐seqspatial transcriptomics

Substances

Transforming Growth Factor betaPOSTN protein, humanCell Adhesion MoleculesInsulin-Like Growth Factor Binding Protein 2

Authors and institutions

  • Department of Plastic Surgery, The Affiliated Friendship Plastic Surgery Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Plastic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Plastic Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Burn and Plastic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Lung Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

ORCID profiles: Songyun Zhao, Jiaheng Xie, Pengpeng Zhang, Wei Yan

Funding

  • Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University

Cite

APA

Zhao, S., Xie, J., Zhang, Q., Ni, T., Lin, J., Gao, W., Zhao, L., Yi, M., Tu, L., Zhang, P., Wu, D., Tang, Q., Ma, C., He, Y., Li, L., Wu, G., & Yan, W. (2025). New Anti‐Fibrotic Strategies for Keloids: Insights From Single‐Cell Multi‐Omics. Cell Proliferation, 58(6). https://doi.org/10.1111/cpr.13818

Vancouver

Zhao S, Xie J, Zhang Q, Ni T, Lin J, Gao W, et al. New Anti‐Fibrotic Strategies for Keloids: Insights From Single‐Cell Multi‐Omics. Cell Proliferation. 2025;58(6). doi:10.1111/cpr.13818

BibTeX
@article{Zhao2025,
  author = {Zhao, Songyun and Xie, Jiaheng and Zhang, Qian and Ni, Tianyi and Lin, Jinde and Gao, Weicheng and Zhao, Liping and Yi, Min and Tu, Liying and Zhang, Pengpeng and Wu, Dan and Tang, Qikai and Ma, Chenfeng and He, Yucang and Li, Liqun and Wu, Guoping and Yan, Wei},
  title = {New Anti‐Fibrotic Strategies for Keloids: Insights From Single‐Cell Multi‐Omics},
  journal = {Cell Proliferation},
  year = {2025},
  volume = {58},
  number = {6},
  doi = {10.1111/cpr.13818}
}
Start for free →